Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -2.16 | $28,353 | -$3M |
| 2025 Q4 | -3.15 | $4,261 | -$927,841 |
| 2025 Q3 | -1.49 | $1,941 | -$1M |
| 2025 Q2 | -1.61 | $0 | -$1M |
| 2025 Q1 | -16.83 | $0 | -$2M |
| 2024 Q4 | -12.94 | $0 | $3M |
| 2024 Q3 |
| -0.78 |
| $0 |
| $25,504 |
| 2024 Q2 | -0.87 | $0 | -$592,320 |